Embla Medical hf.
OSSFF
$4.15
$0.071.72%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 232.42M | 202.79M | 224.78M | 213.53M | 216.73M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 232.42M | 202.79M | 224.78M | 213.53M | 216.73M |
| Cost of Revenue | 87.93M | 75.02M | 82.66M | 79.92M | 78.19M |
| Gross Profit | 144.49M | 127.77M | 142.12M | 133.61M | 138.54M |
| SG&A Expenses | 99.35M | 95.34M | 99.16M | 91.60M | 94.95M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 199.13M | 180.93M | 192.83M | 181.01M | 183.63M |
| Operating Income | 33.29M | 21.86M | 31.95M | 32.52M | 33.10M |
| Income Before Tax | 27.68M | 15.66M | 24.88M | 28.14M | 26.56M |
| Income Tax Expenses | 6.56M | 3.63M | 6.26M | 6.17M | 6.49M |
| Earnings from Continuing Operations | 21.11M | 12.03M | 18.62M | 21.97M | 20.07M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -203.00K | 131.00K | -413.00K | -110.00K | -118.00K |
| Net Income | 20.91M | 12.16M | 18.21M | 21.86M | 19.95M |
| EBIT | 33.29M | 21.86M | 31.95M | 32.52M | 33.10M |
| EBITDA | 40.92M | 27.81M | 38.40M | 40.02M | 40.77M |
| EPS Basic | 0.05 | 0.03 | 0.04 | 0.05 | 0.05 |
| Normalized Basic EPS | 0.04 | 0.02 | 0.04 | 0.04 | 0.04 |
| EPS Diluted | 0.05 | 0.03 | 0.04 | 0.05 | 0.05 |
| Normalized Diluted EPS | 0.04 | 0.02 | 0.04 | 0.04 | 0.04 |
| Average Basic Shares Outstanding | 418.22M | 434.25M | 413.80M | 428.69M | 424.45M |
| Average Diluted Shares Outstanding | 418.22M | 434.25M | 413.80M | 428.69M | 424.45M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |